Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study With a Placebo-Controlled, Double-blind, on the Safety and Efficacy of Etanercept in Palmo-Plantar Pustulosis

NCT00353119 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT00353119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00353119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study With a Placebo-Controlled, Double-blind, on the Safety and Efficacy of Etanercept in Palmo-Plantar Pustulosis
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
March 31, 2007
Enrollment
15 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

palmoplantaris pustulosis